As of March 31, 2026, PHIONX carries a market capitalization of 19.47B, placing it among publicly traded companies globally. Its enterprise value stands at 22.33B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 19.47B |
| Enterprise Value | 22.33B |
As of March 31, 2026, PHIONX has 5.28M shares outstanding.
| Shares Outstanding | 5.28M |
These figures are as of March 31, 2026. The price-to-sales ratio is 11.14, and the price-to-book ratio stands at 0.52.
| PS Ratio | 11.14 |
| PB Ratio | 0.52 |
| P/TBV Ratio | 0.97 |
| P/FCF Ratio | -13.83 |
| P/OCF Ratio | -13.83 |
These figures are as of March 31, 2026. The EV/Sales ratio of 4.19 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 22.33B versus a market cap of 19.47B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 4.19 |
As of March 31, 2026, PHIONX maintains a current ratio of 1.15, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 12.75, indicating elevated leverage, while an interest coverage ratio of -11.34 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.15 |
| Quick Ratio | 0.33 |
| Debt / Equity | 12.75 |
| Debt / EBITDA | -0.91 |
| Interest Coverage | -11.34 |
Over the twelve months ended March 31, 2026, PHIONX posted a negative return on equity (ROE) of -25.80, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -21.75, reflecting losses generated across the asset base. The company generates approximately 260.13M in revenue per employee across its workforce of 20.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 9.35 indicates how many times PHIONX sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -25.80 |
| Return on Assets (ROA) | -21.75 |
| Revenue Per Employee | 260.13M |
| Employee Count | 20.50 |
| Inventory Turnover | 9.35 |
Over the twelve months ended March 31, 2026, PHIONX recorded an income tax benefit of -2.49M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -9.95B and -9.95B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | -2.49M |
As of the close on November 17, 2026, PHIONX's stock has declined approximately 82.80% over the past 52 weeks. The 50-day moving average sits at 1,616.78, while the 200-day moving average is 3,667.59.
| 52-Week Price Change | -82.80% |
| 50-Day Moving Average | 1,616.78 |
| 200-Day Moving Average | 3,667.59 |
Over the twelve months ended March 31, 2026, PHIONX generated 5.33B in revenue and converted that into -9.95B in net income, yielding earnings per share of -617.98. EBITDA reached -5.26B, while operating income came in at -6.20B.
| Revenue | 5.33B |
| Gross Profit | 1.42B |
| Operating Income | -6.20B |
| Pretax Income | -9.95B |
| Net Income | -9.95B |
| EBITDA | -5.26B |
| EBIT | -6.20B |
| Earnings Per Share (EPS) | -617.98 |
As of March 31, 2026, PHIONX holds 1.91B in cash and equivalents against 4.78B in total debt, resulting in a net debt position of 3.65B. Total book value stands at 37.49B, with working capital of 842.27M providing operational flexibility.
| Cash & Cash Equivalents | 1.91B |
| Total Debt | 4.78B |
| Net Debt | 3.65B |
| Equity (Book Value) | 37.49B |
| Book Value Per Share | 7,106.77 |
| Working Capital | 842.27M |
PHIONX produced -4.29B in operating cash flow over the twelve months ended March 31, 2026.
| Operating Cash Flow | -4.29B |
| Free Cash Flow | -4.29B |
| FCF Per Share | -266.74 |
Over the twelve months ended March 31, 2026, PHIONX posted a gross margin of 26.65, reflecting its pricing power and cost economics. The operating margin of -116.28 and net profit margin of -186.56 provide insight into operational efficiency.
| Gross Margin | 26.65 |
| Operating Margin | -116.28 |
| Pretax Margin | -186.60 |
| Profit Margin | -186.56 |
| EBITDA Margin | -98.59 |
These figures cover the twelve months ended March 31, 2026. Free cash flow yield is negative at -7.23: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -41.18, meaning PHIONX raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -41.18 |
| FCF Yield | -7.23 |
PHIONX's most recent stock split took place on June 23, 2026 with a 10:1 split ratio.
| Last Split Date | 6/23/2026 |
| Split Ratio | 10:1 |
As of March 31, 2026, PHIONX has an Altman Z-Score of -10.91, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -10.91 |